arthritis information
First Humira biosimilar approved in Europe
The European Commission has approved Amgevita, a biosimilar to adalimumab (Humira), for all of its available indications. Continue reading
Enzyme discovery could lead to new osteoarthritis treatments
Enzymes appear to play a key role in joint destruction, a finding that could lead to new treatments, says research in Arthritis & Rheumatology. Continue reading
Switching from a biologic to a biosimilar – Jane Scarfe outlines her experience
I was diagnosed with rheumatoid arthritis when I was 48 years old. I had shooting pains in my right arm and terrible fatigue. Continue reading
Prolotherapy may reduce symptoms of knee osteoarthritis
People with osteoarthritis of the knee could benefit from being given injections containing a sugar solution, says a review of the evidence published in British Medical Bulletin. Continue reading
Biomarker discovery could allow prediction of rheumatoid arthritis outcomes
A biomarker has been found that could make it easier to predict which rheumatoid arthritis patients are at most risk of serious illness. Continue reading
